drugset / Trial / NCT00740727

EASI Access II --- Follow-up Study to the EASI Access Trial

NCT00740727 ↗

NaSingle-groupOpen-labelTreatment

Summary

Test whether Basic Life Support (BLS) providers can successfully place Enzymatically Augmented Subcutaneous Infusion (EASI) Access lines for subcutaneous infusion, and characterize intravascular absorption of EASI-administered (tracer-labelled) glucose (D5W).

Timeline

Start
2009-02
Primary completion
2009-03
Completion
2009-03

Publications

Drugs

EvaluationDrugModalityDoseRoute
Background Human recombinant hyaluronidase Protein / enzyme biologic 150 iu Subcutaneous

Indications

No indication recorded.